Tag: AIM ImmunoTech

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to AIM ImmunoTech

Chronic Fatigue Syndrome Market including top key players Hemispherx Biopharma Inc., Torrent ...

Added to Collection on: 2021-02-12 04:52:30

Tags for this article:

Business process
Articles
Health
Business
AIM ImmunoTech
Pharmaceutical industry in China
Chronic fatigue syndrome
Chronic fatigue
Market analysis
Fatigue
Compound annual growth rate
Market research

Click the tags to see associated articles and topics

View Article Details
Global Chronic Fatigue Syndrome Treatment Market Overview 2020 | Hemispherx Biopharma, GP ...

Added to Collection on: 2021-02-26 15:33:45

Tags for this article:

Health
Articles
Chronic fatigue syndrome treatment
Chronic fatigue syndrome
Market analysis
Pharmaceutical industry in China
Chronic condition
Cancer-related fatigue
Competition
AIM ImmunoTech
Chronic fatigue
Fatigue

Click the tags to see associated articles and topics

View Article Details
Global Chronic Fatigue Syndrome Treatment Market Size,Share,Revenue 2027| Hemispherx ...

Added to Collection on: 2021-03-29 09:11:15

Tags for this article:

Medicine
Clinical medicine
Health
Chronic fatigue syndrome
Chronic fatigue syndrome treatment
Cancer-related fatigue
Chronic condition
Chronic fatigue
AIM ImmunoTech
Sjögren syndrome
Fatigue

Click the tags to see associated articles and topics

View Article Details
Chronic Fatigue Syndrome Treatment market growing popularity and emerging trends ...

Added to Collection on: 2021-04-08 17:39:57

Tags for this article:

Medicine
Health
Chronic fatigue syndrome
Exercise physiology
Fatigue
AIM ImmunoTech
Stimulant
Cancer-related fatigue
Pharmaceutical industry in China
Chronic condition
Chronic fatigue
Rintatolimod

Click the tags to see associated articles and topics

View Article Details
NA Proactive news snapshot: Delta 9 Cannabis, North Arrow Minerals, Empower Clinics, NEO ...

Added to Collection on: 2021-06-21 13:52:30

Tags for this article:

Medical specialties
Drugs
Medicine
AIM ImmunoTech
Rintatolimod
Leronlimab
HU-308
Acute respiratory distress syndrome
OTC Markets Group
Pfizer-BioNTech COVID-19 vaccine
Anode
CYTODYN INC

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 ...

Added to Collection on: 2024-04-29 15:55:02

Tags for this article:

Orphan drugs
Rintatolimod
AIM ImmunoTech
Cancer immunotherapy
Checkpoint inhibitor
Durvalumab
Private Securities Litigation Reform Act
PD-L1
Forward-looking statement
AIM ImmunoTech Inc.
Ampligen

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech price target lowered to $1 from $2 at Maxim | Markets Insider

Added to Collection on: 2024-10-22 22:08:28

Tags for this article:

Orphan drugs
Rintatolimod
AIM ImmunoTech
Durvalumab
Endometriosis
Ampligen

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech Executives Forego Bonuses for R&D Focus | Markets Insider

Added to Collection on: 2024-12-24 02:45:06

Tags for this article:

Fabless semiconductor companies
AIM ImmunoTech
Broadcom
NASDAQ
New York Stock Exchange
Intel

Click the tags to see associated articles and topics

View Article Details
AIM ImmunoTech highlights 2024 milestones achieved - Markets Insider

Added to Collection on: 2025-01-15 21:48:33

Tags for this article:

Clinical research
Clinical pharmacology
Clinical trial
Design of experiments
Drug discovery
AIM ImmunoTech

Click the tags to see associated articles and topics

View Article Details
Hemispherx BioPharma (NYSEAMERICAN:HEB) Share Price Passes Above 200 Day ...

Added to Collection on: 2025-01-25 11:51:23

Tags for this article:

AIM ImmunoTech
Rintatolimod
Myalgic encephalomyelitis/chronic fatigue syndrome
HEB
Management of ME/CFS
Short
Real estate investment trust

Click the tags to see associated articles and topics

View Article Details
Book a Demo